{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:01:10Z","timestamp":1776128470597,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12185-020-02914-w","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T05:04:05Z","timestamp":1591592645000},"page":"592-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Extranasal extranodal NK\/T-cell lymphoma associated with systemic lupus erythematosus"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-7197","authenticated-orcid":false,"given":"Satoshi","family":"Ichikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"2914_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/10428194.2016.1183254","volume":"58","author":"H Katsushima","year":"2017","unstructured":"Katsushima H, Fukuhara N, Ichikawa S, Ota Y, Takeuchi K, Ishizawa K, et al. Non-biased and complete case registration of lymphoid leukemia and lymphoma for five years: a first representative index of Japan from an epidemiologically stable Miyagi Prefecture. Leuk Lymphoma. 2017;58:80\u20138.","journal-title":"Leuk Lymphoma"},{"key":"2914_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s12185-019-02609-x","volume":"109","author":"M Yamaguchi","year":"2019","unstructured":"Yamaguchi M, Suzuki R. JSH practical guidelines for hematological malignancies: II Lymphoma-9 Extranodal NK\/T-cell lymphoma, nasal type (ENKL). Int J Hematol. 2019;109:371\u20136.","journal-title":"Int J Hematol."},{"key":"2914_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/ijms21041501","volume":"21","author":"A Saleem","year":"2020","unstructured":"Saleem A, Natkunam Y. Extranodal NK\/T-cell lymphomas: the role of natural killer cells and ebv in lymphomagenesis. Int J Mol Sci. 2020;21:12.","journal-title":"Int J Mol Sci."},{"key":"2914_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12185-010-0726-2","volume":"92","author":"R Suzuki","year":"2010","unstructured":"Suzuki R. Treatment of advanced extranodal NK\/T cell lymphoma, nasal-type and aggressive NK-cell leukemia. Int J Hematol. 2010;92:697\u2013701.","journal-title":"Int J Hematol"},{"key":"2914_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1600-0609.2012.01796.x","volume":"89","author":"JC Jo","year":"2012","unstructured":"Jo JC, Yoon DH, Kim S, Lee BJ, Jang YJ, Park CS, et al. Clinical features and prognostic model for extranasal NK\/T-cell lymphoma. Eur J Haematol. 2012;89:103\u201310.","journal-title":"Eur J Haematol"},{"key":"2914_CR6","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00277-019-03689-9","volume":"98","author":"M Yamaguchi","year":"2019","unstructured":"Yamaguchi M, Suzuki R, Miyazaki K, Amaki J, Takizawa J, Sekiguchi N, et al. Improved prognosis of extranodal NK\/T cell lymphoma, nasal type of nasal origin but not extranasal origin. Ann Hematol. 2019;98:1647\u201355.","journal-title":"Ann Hematol"},{"key":"2914_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.berh.2017.09.013","volume":"31","author":"MY Choi","year":"2017","unstructured":"Choi MY, Flood K, Bernatsky S, Ramsey-Goldman R, Clarke AE. A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017;31:373\u201396.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2914_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.leukres.2018.11.004","volume":"75","author":"A Klein","year":"2018","unstructured":"Klein A, Polliack A, Gafter-Gvili A. Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology. Leuk Res. 2018;75:45\u20139.","journal-title":"Leuk Res"},{"key":"2914_CR9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2914_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521\u201330.","journal-title":"Kidney Int"},{"key":"2914_CR11","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"S Swerdlow","year":"2016","unstructured":"Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2016."},{"key":"2914_CR12","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","volume":"27","author":"M Yamaguchi","year":"2009","unstructured":"Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, et al. Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol. 2009;27:5594\u2013600.","journal-title":"J Clin Oncol"},{"key":"2914_CR13","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00277-014-2137-6","volume":"93","author":"SJ Kim","year":"2014","unstructured":"Kim SJ, Yang DH, Kim JS, Kwak JY, Eom HS, Hong DS, et al. Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK\/T cell lymphoma: CISL08-01 phase II study. Ann Hematol. 2014;93:1895\u2013901.","journal-title":"Ann Hematol"},{"key":"2914_CR14","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, et al. Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009;113:3931\u20137.","journal-title":"Blood"},{"key":"2914_CR15","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1093\/annonc\/mds096","volume":"23","author":"HK Ahn","year":"2012","unstructured":"Ahn HK, Suh C, Chuang SS, Suzumiya J, Ko YH, Kim SJ, et al. Extranodal natural killer\/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis. Ann Oncol. 2012;23:2703\u20137.","journal-title":"Ann Oncol"},{"key":"2914_CR16","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3109\/10428194.2014.974048","volume":"56","author":"WY Kim","year":"2015","unstructured":"Kim WY, Nam SJ, Kim S, Kim TM, Heo DS, Kim CW, et al. Prognostic implications of CD30 expression in extranodal natural killer\/T-cell lymphoma according to treatment modalities. Leuk Lymphoma. 2015;56:1778\u2013866.","journal-title":"Leuk Lymphoma"},{"key":"2914_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","volume":"20","author":"L Song","year":"2018","unstructured":"Song L, Wang Y, Zhang J, Song N, Xu X, Lu Y. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis. Arthritis Res Ther. 2018;20:270.","journal-title":"Arthritis Res Ther"},{"key":"2914_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","volume":"42","author":"S Bernatsky","year":"2013","unstructured":"Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun. 2013;42:130\u20135.","journal-title":"J Autoimmun"},{"key":"2914_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","volume":"73","author":"S Bernatsky","year":"2014","unstructured":"Bernatsky S, Ramsey-Goldman R, Joseph L, Boivin JF, Costenbader KH, Urowitz MB, et al. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis. 2014;73:138\u201342.","journal-title":"Ann Rheum Dis"},{"key":"2914_CR20","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s10067-006-0532-7","volume":"26","author":"JK King","year":"2007","unstructured":"King JK, Costenbader KH. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin\u2019s lymphoma (NHL). Clin Rheumatol. 2007;26:1491\u20134.","journal-title":"Clin Rheumatol"},{"key":"2914_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1177\/0961203309347921","volume":"19","author":"HH Tsang","year":"2010","unstructured":"Tsang HH, Trendell-Smith NJ, Wu AK, Mok MY. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus. Lupus. 2010;19:330\u20133.","journal-title":"Lupus"},{"key":"2914_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1191\/0961203303lu414cr","volume":"12","author":"MH Lin","year":"2003","unstructured":"Lin MH, Huang JJ, Chen TY, Chen FF, Chang KC, Liu MF, et al. EBER-1 positive diffuse large cell lymphoma presenting as lupus nephritis. Lupus. 2003;12:486\u20139.","journal-title":"Lupus"},{"key":"2914_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/BOR.0000000000000202","volume":"27","author":"GC Goobie","year":"2015","unstructured":"Goobie GC, Bernatsky S, Ramsey-Goldman R, Clarke AE. Malignancies in systemic lupus erythematosus: a 2015 update. Curr Opin Rheumatol. 2015;27:454\u201360.","journal-title":"Curr Opin Rheumatol"},{"key":"2914_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/03009742.2014.973061","volume":"44","author":"NS Rasmussen","year":"2015","unstructured":"Rasmussen NS, Draborg AH, Nielsen CT, Jacobsen S, Houen G. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients. Scand J Rheumatol. 2015;44:143\u20139.","journal-title":"Scand J Rheumatol"},{"key":"2914_CR25","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/ar4429","volume":"16","author":"P Hanlon","year":"2014","unstructured":"Hanlon P, Avenell A, Aucott L, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus. Arthritis Res Ther. 2014;16:R3.","journal-title":"Arthritis Res Ther"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02914-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-020-02914-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02914-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:19:30Z","timestamp":1659097170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-020-02914-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2914"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-02914-w","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"10 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}